NeoGenomics Laboratories Inc. (NeoGenomics), located in Florida, has agreed to pay $9,813,260 to resolve allegations that it violated the False Claims Act by providing below fair market value consulting services to certain health care providers that referred beneficiaries to NeoGenomics for laboratory testing services and by paying variable referral-based compensation to independent consultants to identify health care providers that could refer patients to NeoGenomics. In connection with the settlement, the United States acknowledged that NeoGenomics took significant steps entitling it to credit for cooperating with the government’s investigation.
“Federal law prohibits paying remuneration to induce referrals of federal health care services, including by offering services at below fair market value,” said Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division. “We encourage companies to self-disclose improper remuneration and cooperate with our investigations in order to mitigate the consequences of prior conduct.”
“Providing services below fair market value to drive referrals — as alleged here — undermines independent medical judgment,” said Acting Deputy Inspector General for Investigations Miranda L. Bennett of HHS‑OIG. “The Self‑Disclosure Protocol remains an important tool for bringing potential violations to light and ensuring they are addressed appropriately.”
The United States alleged that, as part of NeoGenomics’ Laboratory...
Korean singer and actor IU has asked a U.S. federal court to authorize the release of identifying information from Meta in a move seen as an intention to take strong action against malicious posts...